MAKAYLA BELL: Open Payments
NPI 1265107221 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 14 payments from 8 companies in 2025. Trend: 2023 $675 · 2024 $308 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $166 |
| Astellas Pharma US Inc | 2 | $59 |
| PFIZER INC. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Averitas Pharma Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: Ozempic, Veozah, NURTEC ODT, MOUNJARO, QUTENZA, INSPIRE, JARDIANCE, Wegovy.
Industry payments across AZ — which companies pay providers there.
